Invst, LLC Abb Vie Inc. Transaction History

Invst, LLC

$829 Million
Q3 2024

A detailed history of Invst, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Invst, LLC holds 3,900 shares of ABBV stock, worth $702,000. This represents 0.09% of its overall portfolio holdings.

Number of Shares

3,900

Previous 4,133 5.64%

Holding current value

$702,000

Previous $708,000 8.76%

% of portfolio

0.09%

Previous 0.08%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 19, 2024	SELL	$163.84 - $199.33 $38,174 - $46,443	-233 Reduced 5.64%	3,900 $770,000
Q2 2024 Aug 16, 2024	BUY	$154.79 - $180.76 $119,807 - $139,908	774 Added 23.04%	4,133 $708,000
Q1 2024 May 24, 2024	SELL	$159.82 - $182.1 $117,627 - $134,025	-736 Reduced 17.97%	3,359 $611,000
Q4 2023 Feb 07, 2024	BUY	$137.6 - $154.97 $22,291 - $25,105	162 Added 4.12%	4,095 $634,000
Q3 2023 Nov 21, 2023	BUY	$133.59 - $154.65 $26,450 - $30,620	198 Added 5.3%	3,933 $586,000
Q2 2023 Jul 28, 2023	BUY	$132.51 - $164.9 $2,782 - $3,462	21 Added 0.57%	3,735 $503,000
Q1 2023 Apr 28, 2023	SELL	$144.61 - $166.54 $862,743 - $993,577	-5,966 Reduced 61.63%	3,714 $591,000
Q4 2022 Feb 01, 2023	SELL	$138.31 - $165.87 $95,848 - $114,947	-693 Reduced 6.68%	9,680 $1.57 Million
Q3 2022 Nov 23, 2022	SELL	$134.21 - $153.93 $77,170 - $88,509	-575 Reduced 5.25%	10,373 $1.44 Million
Q2 2022 Aug 11, 2022	BUY	$137.62 - $174.96 $155,785 - $198,054	1,132 Added 11.53%	10,948 $1.54 Million
Q1 2022 May 12, 2022	SELL	$131.98 - $163.75 $43,421 - $53,873	-329 Reduced 3.24%	9,816 $1.48 Million
Q4 2021 Feb 25, 2022	BUY	$107.43 - $135.93 $13,213 - $16,719	123 Added 1.23%	10,145 $1.49 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $46,496 - $52,780	437 Added 4.56%	10,022 $1.08 Million
Q2 2021 Jul 19, 2021	BUY	$105.21 - $117.21 $9,258 - $10,314	88 Added 0.93%	9,585 $1.13 Million
Q1 2021 Jun 23, 2021	SELL	$102.3 - $112.62 $103,220 - $113,633	-1,009 Reduced 9.6%	9,497 $1.06 Million
Q4 2020 Jun 23, 2021	BUY	$80.49 - $108.67 $149,872 - $202,343	1,862 Added 21.54%	10,506 $1.13 Million
Q3 2020 Jun 23, 2021	BUY	$85.91 - $100.83 $49,741 - $58,380	579 Added 7.18%	8,644 $753,000
Q2 2020 Jun 23, 2021	BUY	$73.37 - $98.18 $68,821 - $92,092	938 Added 13.16%	8,065 $800,000
Q1 2020 Jun 23, 2021	BUY	$64.5 - $97.79 $459,691 - $696,949	7,127 New	7,127 $523,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invst, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Invst, LLC with notifications on news.

Account